Abstract |
We describe the identification of MEN15658, a molecule characterized by a promising cytotoxic effect against human tumor cell lines, including platinum- and anthracycline-resistant ovarian carcinoma. MEN15658 induces p53 accumulation, and activation of gadd-45, p21, c-fos and bcl-2 family genes in human ovarian carcinoma A2780 cell line. The compound causes a block in S phase of the cell cycle, inducing apoptotic cell death, thus suggesting an involvement of DNA damage in the MEN15658 effect on tumor cells. The anti-tumoral activity observed against the human ovarian carcinoma A2780 cell line xenotransplanted in nude mice makes this compound a new promising anti-tumoral drug.
|
Authors | Carmela Salvatore, Monica Binaschi, Mario Bigioni, Grazia Camarda, Carlo Alberto Maggi, Cristina Goso |
Journal | Anti-cancer drugs
(Anticancer Drugs)
Vol. 15
Issue 2
Pg. 151-6
(Feb 2004)
ISSN: 0959-4973 [Print] England |
PMID | 15075671
(Publication Type: Journal Article)
|
Chemical References |
- 2-((1,10)phenanthrolin-2-ylhydrazono)-3,4-dihydro-2H-naphthalen-1-one
- Antineoplastic Agents
- CDKN1A protein, human
- Cdkn1a protein, mouse
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins
- GADD45 protein
- Hydrazones
- Intracellular Signaling Peptides and Proteins
- Phenanthrolines
- Proteins
- Proto-Oncogene Proteins c-bcl-2
- Proto-Oncogene Proteins c-fos
|
Topics |
- Animals
- Antineoplastic Agents
(chemistry, pharmacology, therapeutic use)
- Apoptosis
(drug effects)
- Cell Division
(drug effects)
- Cell Survival
(drug effects)
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins
(drug effects, genetics, metabolism)
- Drug Resistance, Neoplasm
(drug effects, genetics, physiology)
- Drug Screening Assays, Antitumor
(methods)
- Female
- Forecasting
- Gene Expression Profiling
(methods)
- Genes, p53
(drug effects, genetics, physiology)
- Humans
- Hydrazones
(chemistry, pharmacology, therapeutic use)
- Intracellular Signaling Peptides and Proteins
- Lung Neoplasms
(pathology)
- Mice
- Mice, Nude
- Ovarian Neoplasms
(pathology)
- Phenanthrolines
(chemistry, pharmacology, therapeutic use)
- Proteins
(drug effects, genetics, metabolism)
- Proto-Oncogene Proteins c-bcl-2
(drug effects, genetics, metabolism)
- Proto-Oncogene Proteins c-fos
(drug effects, genetics, metabolism)
- S Phase
(drug effects)
- Time Factors
- Transplantation, Heterologous
(methods)
- Tumor Cells, Cultured
|